Trial intelligence / Profile preview

3D Visualization of the Anti-obstructive Effect of Levocetirizine

2009-015381-64Phase 4Completed

Sponsor
Clinical Research International
Start
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of levocetirizine in allergic rhinitis (AR), sponsored by Clinical Research International. Primary endpoints: Visualization of effect on nasal cavity dimensions and 24-hour profile of anti-obstructive action. Started Oct 2009; status: completed.

02

Drugs

levocetirizine
03

Conditions

allergic rhinitis (AR)

Beyond the preview

Go deeper on 2009-015381-64.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015381-64.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call